Genesys International Corp Intrinsic Value
Genesys International Corp (GENESYS) median intrinsic value is ₹138.72 from 9 valuation models (range ₹74–₹408), vs current price ₹247.15 — -43.9% downside (Trading Above Calculated Value), margin of safety -78.2%. For current market price and key ratios, visit Genesys International Corp share price today.
GENESYS Valuation Methods Summary — DCF, Graham Number & P/E
Genesys International Corp intrinsic value across 9 models vs current price ₹247.15 — upside/downside and value range per method. Also explore GENESYS share price history to track price trends across different timeframes.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹138.72 | ₹110.98 - ₹166.46 | -43.9% | EPS: ₹11.56, Sector P/E: 12x |
| Book Value Method | asset | ₹278.50 | ₹250.65 - ₹306.35 | +12.7% | Book Value/Share: ₹278.50, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹129.60 | ₹116.64 - ₹142.56 | -47.6% | Revenue/Share: ₹162.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹408.00 | ₹367.20 - ₹448.80 | +65.1% | EBITDA: ₹136.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹98.86 | ₹79.09 - ₹118.63 | -60.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹74.14 | ₹66.73 - ₹81.55 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹95.25 | ₹85.73 - ₹104.78 | -61.5% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹240.00 | ₹216.00 - ₹264.00 | -2.9% | ROE: 8.6%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹269.14 | ₹242.23 - ₹296.05 | +8.9% | EPS: ₹11.56, BVPS: ₹278.50 |
GENESYS Intrinsic Value vs Market Price — All Valuation Models
Genesys International Corp fair value range ₹74–₹408 vs current market price ₹247.15 across 9 valuation models. Browse GENESYS income statement for revenue, profit, balance sheet and cash flow data.
GENESYS Intrinsic Value Analysis — Undervalued or Overvalued?
Genesys International Corp median intrinsic value ₹138.72, current price ₹247.15 — Trading Above Calculated Value by 43.9%, margin of safety -78.2%.
What is the intrinsic value of GENESYS?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Genesys International Corp (GENESYS) is ₹138.72 (median value). With the current market price of ₹247.15, this represents a -43.9% variance from our estimated fair value.
The valuation range spans from ₹74.14 to ₹408.00, indicating ₹74.14 - ₹408.00.
Is GENESYS undervalued or overvalued?
Based on our multi-method analysis, Genesys International Corp (GENESYS) appears to be trading above calculated value by approximately 43.9%.
GENESYS Financial Health — Key Ratios vs Industry Benchmarks
Genesys International Corp financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 14.22 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 8.6% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 39.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.42x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
GENESYS Cash Flow Quality — Operating & Free Cash Flow
Genesys International Corp operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-53 Cr | ₹-62 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹19 Cr | ₹-21 Cr | Positive Operating Cash Flow | 6/10 |
| March 2023 | ₹-35 Cr | ₹-130 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹28 Cr | ₹18 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹19 Cr | ₹13 Cr | Positive Free Cash Flow | 8/10 |